Go Beyond the Boundaries of Status-Quo.
Phlow shatters the Active Pharmaceutical Ingredient (API) and Finished Drug Product (FDP) status quo by revolutionizing the science behind it and creating unprecedented levels of access to life-changing medicines.
Break Through To More Breakthroughs.
Modernizing the way medicines are made
Phlow’s U.S.-based CDMO services accelerate R&D for APIs and Key Starting Materials while seamlessly scaling up cGMP manufacturing—all in one time zone, made in America, with unmatched quality and speed.
Protecting America’s Medicine Cabinet.
Phlow insisted upon change and took action with the U.S Government to rebuild a resilient domestic supply chain capable of manufacturing our most critical medicines and medical countermeasures.
1. “Review of the Food and Drug Administration’s Foreign Drug Inspection Process.” U.S. HHS Office of Inspector General, 2022.
Recent News.
Collaborate with Phlow.
Pioneering life-changing medicines all begins with a conversation. Let’s connect and make the unbelievable happen.